JP2023512729A5 - - Google Patents

Info

Publication number
JP2023512729A5
JP2023512729A5 JP2022548400A JP2022548400A JP2023512729A5 JP 2023512729 A5 JP2023512729 A5 JP 2023512729A5 JP 2022548400 A JP2022548400 A JP 2022548400A JP 2022548400 A JP2022548400 A JP 2022548400A JP 2023512729 A5 JP2023512729 A5 JP 2023512729A5
Authority
JP
Japan
Prior art keywords
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022548400A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023512729A (ja
JP7795466B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/053062 external-priority patent/WO2021160602A1/en
Publication of JP2023512729A publication Critical patent/JP2023512729A/ja
Publication of JP2023512729A5 publication Critical patent/JP2023512729A5/ja
Application granted granted Critical
Publication of JP7795466B2 publication Critical patent/JP7795466B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022548400A 2020-02-10 2021-02-09 モノアシルグリセロールリパーゼ調節因子 Active JP7795466B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062972484P 2020-02-10 2020-02-10
US62/972,484 2020-02-10
PCT/EP2021/053062 WO2021160602A1 (en) 2020-02-10 2021-02-09 Monoacylglycerol lipase modulators

Publications (3)

Publication Number Publication Date
JP2023512729A JP2023512729A (ja) 2023-03-28
JP2023512729A5 true JP2023512729A5 (https=) 2024-02-20
JP7795466B2 JP7795466B2 (ja) 2026-01-07

Family

ID=74595268

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022548400A Active JP7795466B2 (ja) 2020-02-10 2021-02-09 モノアシルグリセロールリパーゼ調節因子

Country Status (22)

Country Link
US (2) US11708359B2 (https=)
EP (1) EP4103557B1 (https=)
JP (1) JP7795466B2 (https=)
KR (1) KR20220140581A (https=)
CN (1) CN115066422B (https=)
AR (1) AR121296A1 (https=)
AU (1) AU2021220539A1 (https=)
BR (1) BR112022015116A2 (https=)
CA (1) CA3169988A1 (https=)
CL (1) CL2022002136A1 (https=)
CO (1) CO2022011275A2 (https=)
CR (1) CR20220376A (https=)
DO (1) DOP2022000162A (https=)
EC (1) ECSP22062460A (https=)
IL (1) IL295447A (https=)
JO (1) JOP20220180A1 (https=)
MX (1) MX2022009804A (https=)
PE (1) PE20221576A1 (https=)
PH (1) PH12022552019A1 (https=)
TW (1) TW202140465A (https=)
UY (1) UY39066A (https=)
WO (1) WO2021160602A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202140465A (zh) * 2020-02-10 2021-11-01 比利時商健生藥品公司 單醯基甘油脂酶調節劑
CN115362151B (zh) 2020-03-26 2025-02-11 詹森药业有限公司 作为单酰基甘油脂肪酶调节剂的芳基哌啶
MX2022011903A (es) 2020-03-26 2023-01-11 Janssen Pharmaceutica Nv Azaspirociclos como moduladores de monoacilglicerol lipasa.
WO2021191391A1 (en) 2020-03-26 2021-09-30 Janssen Pharmaceutica Nv Aminocyclobutanes as monoacylglycerol lipase modulators
US12115154B2 (en) 2020-12-16 2024-10-15 Srx Cardio, Llc Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9)
CA3228446A1 (en) 2021-08-09 2023-02-16 Janssen Pharmaceutica Nv Monoacylglycerol lipase modulators for use in autism spectrum disorders
CA3242372A1 (en) 2021-12-29 2023-07-06 Psy Therapeutics, Inc. Inhibiting monoacylglycerol lipase (magl)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2493637A1 (en) 2002-07-25 2004-02-12 Manuela Villa Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
EP2090576A1 (en) 2008-02-01 2009-08-19 Merz Pharma GmbH & Co.KGaA 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators
KR20140068243A (ko) * 2011-09-30 2014-06-05 얀센 파마슈티카 엔.브이. 대사 질환 및 관련 장애의 치료를 위한 모노아실글리세롤 리파제 억제제
WO2017170830A1 (ja) 2016-03-31 2017-10-05 武田薬品工業株式会社 複素環化合物
EA036637B1 (ru) 2016-03-31 2020-12-02 Такеда Фармасьютикал Компани Лимитед Гетероциклические спиросоединения, ингибирующие моноацилглицерин-липазу
GB201613163D0 (en) 2016-07-29 2016-09-14 Autifony Therapeutics Ltd Novel compounds
MX2020007318A (es) * 2017-09-29 2020-08-24 Takeda Pharmaceuticals Co Compuesto heterociclico.
CN112272670B (zh) 2019-04-16 2023-12-12 上海翰森生物医药科技有限公司 含二并环类衍生物抑制剂、其制备方法和应用
TW202140465A (zh) 2020-02-10 2021-11-01 比利時商健生藥品公司 單醯基甘油脂酶調節劑
CN115362151B (zh) 2020-03-26 2025-02-11 詹森药业有限公司 作为单酰基甘油脂肪酶调节剂的芳基哌啶
MX2022011903A (es) 2020-03-26 2023-01-11 Janssen Pharmaceutica Nv Azaspirociclos como moduladores de monoacilglicerol lipasa.
WO2021191391A1 (en) 2020-03-26 2021-09-30 Janssen Pharmaceutica Nv Aminocyclobutanes as monoacylglycerol lipase modulators

Similar Documents

Publication Publication Date Title
JP2025511899A5 (https=)
JP2021184963A5 (https=)
JP2023171775A5 (https=)
JP2022184985A5 (https=)
JP2023103258A5 (https=)
JP2023166402A5 (https=)
JP2023518821A5 (https=)
JP2023116721A5 (https=)
JP2021028398A5 (https=)
JP2023145572A5 (https=)
JP2022543046A5 (https=)
JP2022541332A5 (https=)
JP2023514727A5 (https=)
JP2022538797A5 (https=)
JP2023552816A5 (https=)
JP2021038271A5 (https=)
JPWO2020148954A5 (https=)
JP2023181322A5 (https=)
JP2022116141A5 (https=)
JP2024045126A5 (https=)
JP2023512729A5 (https=)
JP2020171301A5 (https=)
JP2020120660A5 (https=)
JP2023093656A5 (https=)
JP2023078173A5 (https=)